Highly potent antiviral drug candidates targeting SARS-CoV-2 nsp3 and nsp5
{{output}}
Faced with the repeated emergence of three major epidemics caused by coronaviruses over the past 20 years (SARS-CoV in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019), the development of novel antiviral treatments has become a critical public health priority. ... ...
